Cytori Cell Research Institute Co., Ltd. (3750)

Overview

Cytori Cell Research Institute, Inc., a prominent entity in the medical device sector, is primarily focused on the advancement of cell therapy technologies. Established in 2004 and based in Tokyo, Japan, the company has a rich history of innovation in the field of cell-based treatments, marking its evolution from its previous identity as FRACTALE Corporation. Cytori is actively involved in the research, development, production, and sale of cell therapy related medical devices within the Japanese market. Beyond its core involvement in cell therapy, Cytori extends its business operations into the real estate domain, where it invests in, develops, leases, manages real estate projects, hotels, and offers brokerage services.

Products and Services

Cytori Cell Research Institute, Inc. is known for its diverse range of products and services catering to the medical and healthcare sector, as well as the real estate industry. Below are detailed descriptions of its core offerings:

• Cell Therapy Kits: The company markets a range of specialized kits designed to assist healthcare professionals in the administration of cell therapy. These kits are a direct result of Cytori's extensive research and development efforts in cell therapy technology.
• ECCI-50: A groundbreaking product in Cytori's pipeline targeting the treatment of male stress urinary incontinence and liver cirrhosis. It represents the cutting-edge of cellular therapy aimed at providing effective relief for patients suffering from these conditions.
• Cyt-006: Another innovative offering aimed at preventing postoperative adhesion in patients undergoing surgery for primary rectal cancer. This product underscores Cytori's commitment to improving postoperative outcomes through advanced cell therapy solutions.
• Clinical Trials and Research: Cytori is intensely focused on conducting clinical trials and research in a wide array of disease areas and applications. This includes but is not limited to anterior cruciate ligament repair, bone repair, burn scars, chronic wound healing, critical limb ischemia, anal and Crohn’s disease fistulas, and erectile dysfunction. Such extensive research endeavors highlight the company’s commitment to exploring the vast potential of cell therapy across different medical conditions.
• Real Estate Projects and Hotels: Beyond its healthcare focus, Cytori also invests in a variety of real estate projects and hotels. This diversification into real estate development and management showcases the company's strategic approach to growth and investment.
• Real Estate Brokerage Services: Complementing its direct investment and management of real estate projects, Cytori offers brokerage services. This service ensures a comprehensive real estate solution portfolio, catering to a broad spectrum of client needs in the property market.